Importance of markers of hepatitis B virus in alcoholic liver disease

Saunders, J.B.; Wodak, A.D.; Morgan-Capner, P.; White, Y.S.; Portmann, B.; Davis, M.; Williams, Roger
June 1983
British Medical Journal (Clinical Research Edition);6/11/1983, Vol. 286 Issue 6381, p1851
Academic Journal
Examines the importance of markers of hepatitis B virus infection in patients with alcoholic liver disease. Detection of hepatitis B surface antigen; Comparison between the prevalence of markers of hepatitis B in patients with alcoholic cirrhosis and precirrhotic liver disease; Histological features of patients with markers of hepatitis B virus.


Related Articles

  • Hepatitis C Virus Infection May Lead to Slower Emergence of P. falciparum in Blood. Ouwe-Missi-Oukem-Boyer, Odile; TouréNdouo, Fousseyni S.; Ollomo, Benjamin; Mezui-Me-Ndong, Jérome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; akuwa, Maria; Roques, Pierre; Branger, Michel; Preux, Pierre-Marie; Mazier, Dominique; Bisser, Sylvie // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: Areas endemic for Plasmodium falciparum, hepatitis B virus (HBV) and hepatitis C virus (HCV) overlap in many parts of sub-Saharan Africa. HBV and HCV infections develop in the liver, where takes place the first development stage of P. falciparum before its further spread in blood....

  • Hepatocellular Carcinoma Prevalence and Mortality in a Male State Prison Population. Baillargeon, Jacques; Snyder, Ned; Soloway, Roger D.; Paar, David; Baillargeon, Gwen; Spaulding, Anne C.; Pollock, Brad H.; Arcari, Christine M.; Williams, Brie A.; Raimer, Ben G. // Public Health Reports;Jan/Feb2009, Vol. 124 Issue 1, p120 

    Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their...

  • Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma. Zhong-Jun Wu; Yu Zhu; De-Rong Huang; Zhi-Qiang Wang // Journal of Experimental & Clinical Cancer Research (17569966);2010, Vol. 29, p146 

    Background: Epidemiological studies have clearly validated the association between hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). Patients with chronic HBV infection are at increased risk of HCC, in particular those with active liver disease and cirrhosis. Methods: We...

  • Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Roulot, Dominique; Costes, Jean-Luc; Buyck, Jean-François; Warzocha, Ursula; Gambier, Nicolas; Czernichow, Sébastien; Le Clesiau, Hervé; Beaugrand, Michel // Gut;Jul2011, Vol. 60 Issue 7, p977 

    Background Liver stiffness measurement (LSM) has been used to measure fibrosis in patients with various types of chronic liver diseases. However, its usefulness as a screening procedure in apparently healthy people had not been evaluated to date. Methods 1358 subjects >45 years old from a...

  • High frequency of therapeutic injections, Republic of Moldova.  // Weekly Epidemiological Record;3/19/99, Vol. 74 Issue 11, p84 

    Reports the high frequency of therapeutic injections in Moldova. Association of injections with adverse events; Prevalence of hepatitis B virus infection from administering injections; Attitudes of adults regarding the use of injections to administer medication.

  • CORRECTION: HEPATITIS B VIRUS IN THE UNITED STATES.  // Annals of Internal Medicine;10/4/2011, Vol. 155 Issue 7, p480 

    A correction to a letter to the editor on hepatitis B virus in the U.S. by S. H. Wang, P. Pong, and H. Pollack that was published in the issue 2011 is presented.

  • Hepatitis B Virus Infection – Natural History and Clinical Consequences.  // New England Journal of Medicine;9/16/2004, Vol. 351 Issue 12, p1268 

    A correction to the article �Hepatitis B Virus Infection--Natural History and Clinical Consequences� that was published in the March 11, 2004 issue is presented.

  • A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection. Dienstag, Jules L.; Perrillo, Robert P.; Schiff, Eugene R.; Bartholomew, Maria; Vicary, Catherine; Rubin, Marc // New England Journal of Medicine;12/21/95, Vol. 333 Issue 25, p1657 

    Background: Better treatments for chronic hepatitis B are needed. Lamivudine, the (-)enantiomer of 3'-thiacytidine, is a potent inhibitor of hepatitis B virus (HBV). Methods: In a double-blind trial, we randomly assigned 32 patients with chronic hepatitis B (including 17 who had no response to...

  • Hepatitis B Virus Reactivation in a Patient With Resolved Hepatitis B Virus Infection Receiving Maintenance Rituximab for Malignant B-Cell Lymphoma. Yu Xuan Koo; Tan, Daniel S. W.; Tan, Iain B.; Tao, Miriam; Soon Thye Lim // Annals of Internal Medicine;5/5/2009, Vol. 150 Issue 9, p655 

    A letter is presented concerning a study which aims to report a case of hepatitis B virus (HBV) reactivation in a patient undergoing lymphoma treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics